Galen Growth Asia at BioBiz 2017 – The Big Picture: Understanding Beyond the Pill
Galen Growth Asia is proud to participate to the BioBiz 2017, a biomedical conference organized for students by students aiming to provide an interactive platform to help aspiring graduates and undergraduates gain insights and expose them to the myriad of opportunities available in the biomedical industry.
Julien de Salaberry, Chief Innovation Officer at The Propell Group Co-Founder of Galen Growth Asia will be speaking, along with Dr Ong Siew Hwa and Dr Carl Firth, at the panel The Big Picture: Understanding Beyond the Pill.
This panel will be focusing on issues with regards to the BioTech industry. Biotechnology is technology based on biology, it involves harnessing cellular and biomolecular processes to develop technology and products to improve our lives. As an industry, BioTech mainly comprises of two parts – the use of living organisms to develop products and pharmaceutics. According to PWC, the global pharmaceutical market could be worth nearly $1.6 trillion in 2020. Furthermore, with new tools being developed, better medicines can be materialised. With our esteemed panellists, we will be discussing about the current and future developments in terms of research & development, translation of research to product and manufacturing. The market and employment trends in Singapore and the region will also be touched on.
Starting from 2006, BioBiz is a flagship event of the National University of Singapore (NUS) organised by students from NUS and the Nanyang Technological University (NTU). This close collaboration has brought forth successful conferences which have benefitted more than 5000 participants over the years